Comparison of cystatin-C and pentraxin-3 in coronary atherosclerosis
Authors:
- Yusuf C. DoganerYDYusuf C. Doganer
- Umit AydoganUAUmit Aydogan
- Mustafa AparciMAMustafa Aparci
- Polat NerkizPNPolat Nerkiz
- Cem BarcinCBCem Barcin
- Tuncer CayciTCTuncer Cayci
- Oktay SariOSOktay Sari
- 1 November 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 25 (7) , 589-594
Abstract
Inflammation is one of the numerous factors that promote atherosclerosis. Cystatin-C (Cys-C) and pentraxin-3 (PTX-3) predominantly play roles in inflammation. Thus, we evaluated whether these markers were related to the presence and severity of coronary artery disease (CAD). Eighty-two stable patients who had undergone coronary angiography were enrolled in the study. Patients were diagnosed with significant (>50% stenosis) and nonsignificant (<50% stenosis) CAD. Patients with diabetes, chronic heart failure, chronic kidney disease, and so on were excluded from the study. Patients without CAD had higher Cys-C levels compared with those with CAD (1338.96±396.71 vs. 853.69±406.72 ng/ml, P<0.001). However, the PTX-3 level was inversely lower in patients without CAD (110.40±48.10 vs. 149.46±49.44 pg/ml, P=0.001). The Cys-C level was found to be 677.11±335.56, 1024.18±401.21, and 1338.96±396.71 ng/ml in patients with significant CAD and nonsignificant CAD, and healthy individuals, respectively (P<0.001). The PTX-3 level was inversely reduced in these groups: 168.43±49.09, 131.14±43.10, and 110.40±48.10 pg/ml, respectively (P<0.001). We observed that the levels of Cys-C and PTX-3 were inversely varied in the same study groups. These parameters may aid detection of the presence or identification of the severity of CAD when used in combination. Determinative values could exactly be described in the large study groups.Keywords
This publication has 17 references indexed in Scilit:
- Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory ResponseMediators of Inflammation, 2012
- Pentraxin 3 as a Novel Marker Predicting Congestive Heart Failure in Subjects With Acute Coronary SyndromeKorean Circulation Journal, 2010
- Associations of Pentraxin 3 With Cardiovascular Disease and All-Cause DeathArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Role of Inflammation in AtherosclerosisJournal of Nuclear Medicine, 2007
- Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigmEuropean Heart Journal, 2007
- Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina PectorisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurementKidney International, 2004
- Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysmsBritish Journal of Surgery, 2001
- Cystatin C deficiency in human atherosclerosis and aortic aneurysmsJournal of Clinical Investigation, 1999
- Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.Journal of Clinical Investigation, 1998